Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

sections

Multiple pharmacies

Lloyds may face pharmacy closures if Sainsbury’s deal goes ahead

Lloydspharmacy may have to sell branches in 13 areas of the UK if it wants to go ahead with the £125m deal to acquire 277 Sainsbury’s instore pharmacies and another four that the supermarket chain runs in NHS trusts.

The Competition and Markets Authority (CMA) – which has been investigating the business plan since December 2015 – has identified 13 districts where it believes competition would be reduced if the proposals go ahead, because of the proximity of existing Lloydspharmacy branches.

If the acquisition goes ahead in those districts it “may lead to adverse effects for customers in terms of a reduction in the quality of service provided”, according to the CMA’s provisional findings published on 29 April 2016. A takeover by Lloydspharmacy of Sainsbury’s pharmacies within NHS trusts would not have a similar impact because of limited competition in this market, it adds.

Simon Polito, chair of the CMA independent inquiry panel that has led the investigation, says: “We found evidence that there were some differences in the characteristics of Sainsbury’s and Lloydspharmacy customers but we also found that customers would be willing to switch between Lloyds and Sainsbury’s pharmacies, particularly where the number of convenient competitor pharmacies was low.

“We have provisionally found that after the merger Lloyds will no longer face sufficient competition in 13 areas and expect that in these areas customers will lose out. We are now inviting responses to these provisional findings and will discuss ways in which we can address our concerns.”

The CMA invites comments on its provisional findings by 23 May 2016 before making a final decision in June 2016. 

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2016.20201100

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Sainsbury's store frontage

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.